NYSE · Analyst Forecast

Dr. Reddy's Laboratories Ltd (RDY) Stock Forecast & Price Target

$14.79 NYSE: RDY Market Cap $12.33B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Dr. Reddy's Laboratories Ltd (RDY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Dr. Reddy's Laboratories Ltd, analysts forecast revenue rising from INR 277.32B in 2024 to INR 439.31B in 2029; the average estimate for 2029 earnings per share is INR 73.81; with published estimates ranging from INR 71.36 to INR 79.00; 19 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$14.79
Consensus targetThe average of the price targets analysts have published.$14.35
Median targetThe middle target, less affected by a single outlier.$14.35
Highest targetThe most optimistic published target.$14.80
Lowest targetThe most pessimistic published target.$13.90
Difference from priceHow far the consensus target sits from today’s price.-3.0%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (INR)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024INR 276.49BINR 277.32BINR 301.76B13
2025INR 316.04BINR 321.22BINR 325.54B18
2026INR 342.36BINR 345.08BINR 347.81B18
2027INR 352.43BINR 355.32BINR 360.15B18
2028INR 391.10BINR 398.94BINR 410.70B19
2029INR 428.05BINR 439.31BINR 463.04B9

Earnings per share forecast (INR)

YearLowAverageHighAnalysts
2024INR 64.02INR 64.18INR 64.6713
2025INR 64.10INR 67.47INR 69.1618
2026INR 57.27INR 60.13INR 63.9518
2027INR 41.99INR 43.90INR 44.8518
2028INR 53.09INR 59.10INR 66.1119
2029INR 71.36INR 73.81INR 79.009

Dr. Reddy's Laboratories Ltd (RDY) forecast — frequently asked questions

What is the analyst price target for Dr. Reddy's Laboratories Ltd?

Analysts covering Dr. Reddy's Laboratories Ltd (RDY) have a consensus price target of $14.35, 3.0% below the current price of $14.79. Published targets range from $13.90 to $14.80. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Dr. Reddy's Laboratories Ltd's earnings?

The average analyst estimate for Dr. Reddy's Laboratories Ltd (RDY) earnings per share in 2029 is 73.81, with individual estimates between 71.36 and 79.00.

How much revenue is Dr. Reddy's Laboratories Ltd expected to make?

Analysts forecast Dr. Reddy's Laboratories Ltd (RDY) revenue of INR 439.31B in 2029, based on 9 published estimates.

How many analysts cover RDY?

19 analysts contribute estimates for Dr. Reddy's Laboratories Ltd (RDY). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastRGC stockAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.